Sunwels Co.,Ltd. (TYO:9229)
570.00
+45.00 (8.57%)
May 16, 2025, 3:30 PM JST
Sunwels Revenue
Sunwels had revenue of 7.21B JPY in the quarter ending December 31, 2024, with 37.28% growth. This brings the company's revenue in the last twelve months to 25.96B, up 41.77% year-over-year. In the fiscal year ending March 31, 2024, Sunwels had annual revenue of 20.11B with 51.91% growth.
Revenue (ttm)
25.96B
Revenue Growth
+41.77%
P/S Ratio
0.67
Revenue / Employee
10.66M
Employees
2,435
Market Cap
17.28B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 20.11B | 6.87B | 51.91% |
Mar 31, 2023 | 13.24B | 5.06B | 61.93% |
Mar 31, 2022 | 8.17B | 2.77B | 51.26% |
Mar 31, 2021 | 5.40B | 1.03B | 23.41% |
Mar 31, 2020 | 4.38B | 950.85M | 27.74% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Takeda Pharmaceutical Company | 4,581.55B |
Daiichi Sankyo Company | 1,886.26B |
HOYA Corporation | 869.37B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Olympus | 997.33B |